Fiche société
BioDelivery Sciences International
Traitements, essais et publications liés.
Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| DFN-15 ActiveEfficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States. | Migraine | Phase 3 | À vérifier | United States | À vérifier |
| DFN-15 ActiveEfficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States. | Migraine | Phase 3 | À vérifier | United States | À vérifier |
| DFN-15 ActiveEfficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States. | Migraine | Phase 3 | À vérifier | United States | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| DFN-15 Active | Migraine | Phase 3 | NCT03009019 | Efficacy, Tolerability, and Safety of DFN-15 | COMPLETED |
| DFN-15 Active | Migraine | Phase 3 | NCT03006276 | Efficacy, Tolerability, and Safety Study of DFN-15 | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||